Crescendo Biologics announces cancer research collaboration
Crescendo Biologics appoints Dr Igor Matushansky as Non-Executive Director
Crescendo Biologics appoints non-executive director
Crescendo Biologics reaches first major milestone in strategic collaboration with Takeda
Dani Bach joins Crescendo Biologics
Crescendo Biologics expands ADC programmes with Innovate UK grant
Mike Romanos wins promotion
Multi million pound seed funding enables Crescendo Biologics to advance fragment antibody technology
